Pharma, patient advocates clash over Inflation Reduction Act

Pharma, patient advocates clash over Inflation Reduction Act

Source: 
Clinical Trials Arena
snippet: 

The Inflation Reduction Act, which became US law in August 2022, has invited its fair share of critics and supporters over its drug pricing provisions. At a lively panel at Financial Times US Pharma and Biotech Summit on May 16, panellists were at odds over whether the new legislation would improve treatment affordability or stifle pharma innovation.